Pharmacogenomics and public health: implementing ‘populationalized’ medicine
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacogenomics and public health: implementing ‘populationalized’ medicine
Authors
Keywords
-
Journal
PHARMACOGENOMICS
Volume 13, Issue 7, Pages 803-813
Publisher
Future Medicine Ltd
Online
2012-05-18
DOI
10.2217/pgs.12.52
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Conference Scene: Golden Helix Pharmacogenomics Days: educational activities on pharmacogenomics and personalized medicine
- (2012) Alessio Squassina et al. PHARMACOGENOMICS
- Institutional Profile: Golden Helix Institute of Biomedical Research: interdisciplinary research and educational activities in pharmacogenomics and personalized medicine
- (2012) Konstantinos Mitropoulos et al. PHARMACOGENOMICS
- Critical appraisal of the private genetic and pharmacogenomic testing environment in Greece
- (2011) Aggeliki Sagia et al. Personalized Medicine
- A critical view of the general public’s awareness and physicians’ opinion of the trends and potential pitfalls of genetic testing in Greece
- (2011) Yuan Mai et al. Personalized Medicine
- Pharmacogenomic technologies: a necessary "luxury" for better global public health?
- (2011) Catherine Olivier et al. Globalization and Health
- A framework for mandatory impact evaluation to ensure well informed public policy decisions
- (2010) Andrew D Oxman et al. LANCET
- Applying the genome to national drug formulary policy in the developing world
- (2010) Mary W Roederer et al. PHARMACOGENOMICS
- Realities and expectations of pharmacogenomics and personalized medicine: impact of translating genetic knowledge into clinical practice
- (2010) Alessio Squassina et al. PHARMACOGENOMICS
- Population-specific documentation of pharmacogenomic markers and their allelic frequencies in FINDbase
- (2010) Marianthi Georgitsi et al. PHARMACOGENOMICS
- Cutaneous leishmaniasis: disease susceptibility and pharmacogenetic implications
- (2009) Mahreen Ameen PHARMACOGENOMICS
- Clinical Implications of CYP2D6 Genotyping in Tamoxifen Treatment for Breast Cancer
- (2008) V. O. Dezentje et al. CLINICAL CANCER RESEARCH
- A Review of Public Policy Issues in Promoting the Development and Commercialization of Pharmacogenomic Applications: Challenges and Implications
- (2008) Louis P. Garrison et al. DRUG METABOLISM REVIEWS
- South Africa: from species cradle to genomic applications
- (2008) Billie-Jo Hardy et al. NATURE REVIEWS GENETICS
- From diversity to delivery: the case of the Indian Genome Variation initiative
- (2008) Billie-Jo Hardy et al. NATURE REVIEWS GENETICS
- Genomics, public health and developing countries: the case of the Mexican National Institute of Genomic Medicine (INMEGEN)
- (2008) Béatrice Séguin et al. NATURE REVIEWS GENETICS
- Universal health care, genomic medicine and Thailand: investing in today and tomorrow
- (2008) Béatrice Séguin et al. NATURE REVIEWS GENETICS
- Genomic medicine and developing countries: creating a room of their own
- (2008) Béatrice Séguin et al. NATURE REVIEWS GENETICS
- Amodiaquine pharmacogenetics
- (2008) Jose Pedro Gil PHARMACOGENOMICS
- Pharmacogenomics of anti-TB drugs-related hepatotoxicity
- (2008) Puspita Das Roy et al. PHARMACOGENOMICS
- Developing Stakeholder Involvement for Introducing Public Health Genomics into Public Policy
- (2008) H. Burton et al. Public Health Genomics
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started